.L. 3.. , . . , ,_ . . V V ._. . .V . V ,, 7 , V . V . v .4 V . : . V V . . y 4 _ .. . _ V . . . . _ ‘ , .. .y1t... . V . . V v, V . 1 . ... “455‘s This is to certify that the thesis entitled HORMONAL CONTROL OF TUBULIN CONTENT AND POLYMERIZA‘I‘ION IN RAT LIVER presented by Rosalyn M. Zator has been accepted towards fulfillment l of the requirements for .__M;S_.___degree in MS try W4 Major professor MM 0-7639 OVERDUE FINES: 25¢ per day per item RETURNING LIBRARY MATERIALS: Place in book return to remove charge from circulation records HORMONAL CONTROL OF TUBULIN CONTENT AND POLYMERIZATION IN RAT LIVER By Roselyn Mary Zator A THESIS Submitted to Michigan State University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Department of Biochemistry 1979 ABSTRACT HORMONAL CONTROL OF TUBULIN CONTENT AND POLYMERIZATION IN RAT LIVER BY Roselyn Mary Zator The starved-refed rat and the streptozotocin induced diabetic rat were used as models to study microtubule reg- ulation. The method of Pipeleers and co-workers (J‘,le1 giglg‘zfi, 3&1-350. 1977). which includes a colchicine binding assay, was used to quantitate soluble free and polymerized tubulin. During starvation and diabetes. the percent of liver tubulin polymerized was decreased com- pared to control levels. Refeeding starved rats and ins jecting insulin into diabetic rats resulted in an increase in the degree of tubulin polymerization. Tubulin content and polymerization changed in the starved-rated rat liver due to polymeric tubulin while in the diabetic rat liver the change was due to free tubulin. Fluctuations in the degree of polymerization in the starved-refed rat liver may be correlated to VLDL secretion from the liver. Plasma glucose and insulin levels. and liver cAMP and cGMP levels did not appear to directly affect tubulin content or polymerization. The method of quantitating ig;zizg free and polymerized tubulin was investigated to verify that actual isolation of the in give situation had been accomplished. DEDICATION To my parents. Henry and Henrietta Zator and my loving husband. Dennis M. Wojcik for their constant love, patience. and understanding. ii ACKNOWLEDGEMENTS I wish to express my appreciation to Dr. William W. Wells for his understanding. guidance, patience, and financial support throughout these studies. Sincere thanks goes to my committee members. Dr. Philip Filner and Dr. Steve Heidemann for their suggestions. I would also like to express my eternal gratitude and appreciation to Jeffrey A. Nickerson without whose guidance. support, encouragement. and friendship none of this would have been possible. Special thanks to James Kurtz. Christine Collins, and Greg Doll for their intellectually stimulating conversations. Last but not least I would like to thank my ever so patient husband and family for their everlasting moral support. iii TABLE OF CONTENTS LIST OF TABLES. . . . . . . . LIST OF FIGURES . . . . . . 0 LIST OF ABBREVIATIONS . o . . INTRODUCTION. 0 o o . . . . . Objectives . . . . . . . Literature Search. . . . . Bibliography e e o e e CHAPTER I: TUBULIN CONTENT AND THE STARVED-REFED Abstract 0 o o e e e 0 Introduction . . . . . Materials and Methods. ROSUltS. e e o e o o 0 Discussion . . . . . . Bibliography 0 e o e 0 CHAPTER II: EXAMINATION OF THE ‘ QUANTITATING FREE AND POLYMERIZED TUBULIN. . o . . Abstract 0 e o o o e 0 Introduction . . . . . Methods and Materials. ROSUItBo o e e o e o 0 Discussion . . . Bibliography . . CHAPTER III: LIVER TUBULIN CONTENT AND POLYMERIZATION IN THE INDUCED DIABETIC RAT. . 0 Abstract 0 e e o e e 0 Introduction . . . . . Materials and Methods. RGSU1tSe o o o o o o 0 Discussion . . . Bibligraphy. . . I I I I I I I I I v I I I I I I I I I vi 0 e o o o o o e 0V111 I I I I I I I I I 1 I I I I I 1 . . o 2 I I I I 18 POLYMERIZATION IN RAT LIVER . . . . 26 I I I I I I I I I 26 I I I I I I I I I 2? I I I I I I I I I 28 I I I I I I I I I 33 I I I I I I I I I “8 I I I I I I I I I 57 METHOD OF I I I I I I I I I 60 I I I I I I I I I 60 I I I I I I I I I 61 I I I I I I I I I 62 I I I I I I I I I 6+ I I I I I I I I I 73 I I I I I I I I I 76 STREPTOZOTOCIN . . . . 77 I I I I I I I I I 77 I I I I I I I I I 78 I I I I I I I I I 79 I I I I I I I I I 81 I I I I I I I I I 91 I I I I I I I I I 94 LIST OF TABLES CHAPTER I I. Food Consumption and Body and Liver‘Weights of Starved Rats Refed a High Glucose Diet . . 38 II. Liver Protein. DNA, and Protein/DNA in Starved-Refed Rats. o o e o o o e o e o o e o 40 III. The Degree of Tubulin Polymerization and Amount of Tubulin per Protein in the Starved- Refed Rat Liver e e o e o e o o o o e e o e e “3 CHAPTER II I. The Effect of Tissue Dilution on the Degree of Tubulin Polymerization . . . . . . . . . . 65 II. The Effect of Tissue Dilution on the Percent of Tubulin.Polymerized and Total Tubulin content I I I I I I I I I I I I I I I I I I I 66 CHAPTER III I. Protocol of Experiment and Body Weight of RatSe e e e e o o o o e e o e e o o e e o o e 82 II. Plasma Glucose and Insulin Levels. Liver Protein Content. and Total Liver Tubulin Based on Protein Content. . . . . . . . . . . 83 CHAPTER I I. LIST OF FIGURES Protocol Used for Determining the Amount of Free and Polymerized Tubulin in the Starved- Refed Rat Liver. e o o o o e e o o e o o e e 31 II. Kinetics of Colchicine Binding Activity in MTS and TS o o e o e o o o e o o o e e e o o 35 III. Liver Free and Polymerized Tubulin and the Degree of Tubulin Polymerization in the Starved-Refed Rat. o e o o o o e e o o e o 0 IV. Free and Polymerized Tubulin Based on DNA in the Starved-Refed Rat Liver. e o o o e o o o 7 V. Plasma Glucose and Insulin Levels in the Starved‘Refed Rate 0 o e o e e o o o o o e e 50 VI. Liver cAMP and cGMP Levels in the Starved- ' Refed Rate a o o e e e o e e o o e o e o e e 52 CHAPTER II I. The Effect of Tissue Dilution on the Linearity of Colchicine Binding Activity in MTS and TS I I I I I I I I I I I I I I I I I 67 II. The Effect of Tissue Dilution on the Linearity of Colchicine Binding.Activity in MTS and T5 0 e o e e e o o o o e e o o o e 0 III. Colchicine Binding of Liver Tubulin in MTS or TSI I I I I I I I I I I I I I I I I I I I 70 IV. Colchicine Binding of Brain Tubulin in MTS or TSe e o e e e o o o e o e o e o o o e o e 71 v. In Vitro Polymerization Studies Using MTS BEerr and.Assembly Buffer with a Tubulin Concentration of 600 ug/ml . . . . . . . . . 72 vi vii CHAPTER'III I. II. III. The Degree of Tubulin Polymerization in the Streptozotocin Induced Diabetic Rat Liver. . . 86 The Amount of Free and Polymerized Tubulin per Gram Liver in the Streptozotocin Induced Diabetic Rat . . . . . . . . . . . . . 88 The.Amount of Free and Polymerized Liver Tubulin per Mg DNA in the Streptozotocin Induced Diabetic Rat . . . . . . . . . . . . . 90 DEAE GTP ATP EGTA GDP GMPPCP MAPS GMPPNP cAMP cGMP VLDL MES DMSO TCA BW LIST OF ABBREVIATIONS Diethylaminoethyl Guanosine-S'-triphosphate Adenosine-S'-triphosphate Ethylene glycol bis ( - aminoethyl ether) N. N. N', N' tetraacetic acid Guanosine-5'-diphosphate 5'-guanylylmethylene diphosphonate Microtubule associated proteins Guanyl-S'-yl-imidodiphosphate Cyclic adenosine monophosphate Cyclic guanosine monophosphate Very low density lipoprotein 2-(N-morpholino)ethanesulfonic acid Dimethylsulfoxide Trichloroacetic acid Body‘weight viii INTRODUCTION Objectives and Organization The regulation of tubulin polymerization is not well understood. Tubulin polymerization. in vitro. has been extensively investigated. Though several mechanisms have been elucidated; a controversy still exists concerning these mechanisms. There is. therefore. a need to identify model systems in 1119 in which tubulin content and poly- merization can be experimentally manipulated and studied. The starved-refed rat and the streptozotocin induced dia- betic rat before and after insulin treatment are two such systems. The purpose of these studies is to: 1. Identify model systems in which tubulin con- tent and polymerization can be experimental- ly manipulated. 2. Elucidate the role of microtubules in these systems. 3. Determine whether physiological factors con- trol microtubule dependent processes through alterations in the equilibrium between free and polymerized tubulin. 2 Chapter 1 deals with the regulation of tubulin con- tent and polymerization in the starved-refed rat liver. Chapter 2 examines the method used to measure free and polymerized tubulin. Chapter 3 deals with the regulation of tubulin content and polymerization in the streptozoto- cin induced diabetic rat with and without insulin treat- ment. Wm Micrctubules have been implicated in a wide variety of cellular processes such as secretion. intracellular trans- port. mitosis, cell motility. maintenance of cell shape. and integrity of cell membrane receptors. The mechanism by which microtubules participate in these processes may involve the dynamic equilibrium between free and polymer- - ized forms of tubulin, the major microtubule protein. More specifically. microtubular involvement in movement may be regulated by the control of tubulin polymerizaticn~ (1-5). However. the factors or conditions influencing assembly and disassembly are not well understood. A major obstacle to studying the regulation of microtubules is the lack of a reliable and valid assay for microtubules or tubulin. With the aid of tritiated colchicine (6), Borisy and Taylor (3,?) found that colchicine binding activity was highest in sources known to be rich in microtubules. such 3 as mitotic spindles, cilia, sperm tails, and brain. and concluded that the colchicine binding protein was a subunit of microtubules. Weisenberg. Borisy, and Taylor (8) were the first to isolate and purify the colchicine receptor from supernatant extracts from porcine brain by ammonium sulfate fractionation and ion-exchange chromatography on DEAE Sephadex. The protein was subsequently identified as the microtubule protein (9,10). Tubulin is a dimer having a mass of 100,000-130,000 Daltons and a 320,w of 68. When denatured in guanidine hydrochloride or sodium dodecyl sulfate two subunits of approximately the same size are found. The dimer binds one mole of colchicine and two moles of GTP (8.11); of the two nucleotide binding sites only one is exchangeable. Col- chicine binds tubulin, inhibits assembly, and reverses assembly causing disassembly in 3119 and in 31333 (11,13, 14). Colchicine binding activity of tubulin is unstable and decays rapidly in vitgg. Agents which stabilize the activity include colchicine itself, GTP, Mg*2, lyophil- lization, moderate ionic strength. pH 6.7-6.8, and vinblas- tine (8.12.15). Recently Margolis and Wilson (14) proposed that colchicine blocks microtubule assembly by binding to tubulin which then binds to the growing end of the micro- tubule during assembly and blocks further assembly. Studies (16,17,129), showing protein molecules in mammalian brain interacting with the colchicine site in tubulin, indicate that this site may have a significant role in the in vivo regulation of tubulin polymerization. L. The highly specific and essentially irreversible bind- ing of colchicine to tubulin (15) has allowed it to be used as a tool to assay for tubulin. Tritiated-colchicine binding assays must include a step to separate the colchicine- tubulin complex from free colchicine. Gel filtration. ionic adsorption. and adsorption of the free colchicine on acti- vated charcoal have been used. The gel filtration method involves the separation of tubulin-colchicine complex and free colchicine via the column (3.18). The second method depends on the adsorption of the highly acidic tubulin- colchicine complex to the DEAE groups on the paper and filtering or washing away the free colchicine (8.19). With the activated charcoal method. free colchicine is adsorbed by the charcoal. thereby accomplishing separation of the free colchicine and colchicine-tubulin complex (20). Other methods have been designed to assay for tubulin with- out the use of the drug colchicine. for instance antibodies have been used in radioimmuncassays as well as immuno- fluorescent probe assays (21.24). Electron microscopy has also been used to quantitate microtubules (25). In an attempt to understand ;p_zixg microtubule as- sembly. ig gitgg polymerization systems have been developed. ‘Weisenberg (26) was the first to achieve polymerization in zijgg in a temperature dependent system. Borisy and Olmsted (27) confirmed his results. Weisenberg showed that in vitro polymerization of rat brain tubulin requires Mg+2. ATP or GTP. EGTA to chelate CaIZ, and 37 C. Shelanski. 5 Gaskin. and Cantor (28) subsequently) designed a method to purify tubulin based on its ability to polymerize and depolymerize. They also showed that microtubule assembly could occur in the absence of added nucleotides in the presence of 1M sucrose or #M glycerol. Micretubule polymerization in extracts of mammalian tissue has been measured using viscometry. electron microscopy. turbidity. and optical diffraction (13.26.28-31). Microtubule assembly is dependent on temperature. pH. Ca+2 concen- tration. Mg+2 concentration. ionic strength. and tubulin concentration. In polymerization studies. preparation from different species behave differently. The age of the animal may influence polymerization ability (32. 33). Besides tubulin from brain. tubulins from platelets (3h-37). bovine renal medullary tissue (38). drosophila embryo (39). Ehrlich ascites tumor cells (#0). and HeLa cells (hl.h2) have been polymerized in ziggg. Guanine nucleotides have been found bound to tubulin (8.43). Tubulin contains two binding sites for GTP. an exchangeable site which readily exchanges phosphate with the medium. and the nonexchangeable site which binds tightly and does not exchange with the medium. GTP is normally required for tubulin poly- merization (26.29.u4.u5). In the presence of high con~ centrations of sucrose or glycerol. GTP was not required for polymerization (28). Though no depolymerization 6 occurred in glycerol and occurred in sucrose only under abnormal conditions. Occupancy of the exchangeable site by GTP is necessary for polymerization but polymerization may occur in the presence of GDP and ATP by a transphos- phorylase reaction (46). A controversy exists about whether hydrolysis of GTP is required for polymerization. Inves- tigators have seen polymerization in the presence of the nonhydrolyzable analogs. GMPPCP and GMPPNP (47.48). The hydrolysis of GTP to GDP may not be required for microtubule polymerization but rather for the subsequent depolymerization of the microtubule formed (45.47.49). Tubulin purified through several cycles of polymeriza- tion and depolymerization has been found to contain a small fraction of other proteins called Microtubule Associated Proteins (MAPS) (50-53.68). The MAPs (53) which can be separated from tubulin by chromatography techniques have been found to influence the rate and extent of polymeriza- tion ip,gitgg (51.55-58). Brain tubulin can be polymerized in the absence of MAP8 but a high concentration of tubulin is required (59.60). A class of MAP3 has been identified as High-MolecularAWeight proteins (BMW) of subunit molecular weight 275.000 to 350.000. These HMW proteins have been visualized by electron microscopy as a filamentous coating on the surface of microtubules. in gitgg and ig,z§zg (55. 58.61.62). These HMW proteins may bridge microtubules to each other or to other structures such as cellular organelles. They may have a motile function and be directly involved in 7 the translocation of particles and organelles (55). Sherline. Lee. and Jacobs (63) have found that the EMT proteins asso- ciated with microtubules are preferentially adsorbed by secretory granules and that they may provide the link be- 'tween tubulin and the secretory granule. This is evidence for microtubule involvement in intracellular movement of secretory granules. Recently Nunez and cc-workers (17) have found that HMW proteins and tau proteins competitively inhibit colchicine binding to tubulin. These proteins may bind at or near the same site as colchicine or modify the affinity of the colchicine binding site and therefore may play a role in the regulation of microtubule function and assembly. Some investigators believe that polymerization is promoted by a mixture of 4 or 5 polypeptides of molecular weights between 50.000 and 70.000 Daltons which they col- lectively call tau (52.64-66). Recent observations show that fluorescein-conjugated antiserum to pig brain tau pro- tein stains a colcemid-sensitive network in interphase mouse embryo fibroblasts and mitotic spindles in dividing cells. suggesting some ig_zizg function for tau protein in the microtubule (67). Several mechanisms of microtubule assembly have been proposed. Kirschner and co-workers (25) proposed that microtubules consist of proteins which were initially both in the ring form and the tubulin dimer. Rings and tubulin dimers sequentially form ribbons. sheets. and then a cylin- drical structure containing the 13 protofilaments. the . ag~ ”y.“ . “h-.."- 8 microtubule. Vallee and Borisy (68) have investigated the forms found in tubulin preparations through analytical sedi- mentation techniques. Their findings are that 308 oligomers, are tubulin double rings with HM" proteins. 398 oligomers are 308 rings stripped of their BMW proteins. 188 oligomers are tubulin with HMW proteins but not in a ring form. and 208 oligomers are single rings with tau. These oligomers do not have to be intermediates for microtubule assembly. moreover it appears that multiple pathways to the formation of microtubules may exist depending on the protein composi- tion of the preparation and the nature of the oligomers present (68). It has been reported that tubulin preparations contain a cAMP dependent protein kinase as well as a cAMP indepen- dent protein kinase. both of which phosphorylate tubulin and MAP8. Goodman and co-wcrkers (73) preposed that puri- fied brain tubulin is both a cAMP dependent protein kinase and a substrate for this enzymatic activity,tand that phos- phorylation was related to polymerization. Scifer (70) because of his unsuccessful attempt to separate protein kinase activity from tubulin agreed that cAMP dependent protein kinase was intrinsic to the tubulin itself. Recent- ly Ikeda and Steiner (36) have found cAMP independent pro- tein kinase activity in platelet tubulin that seems to be an intinsic property for its lack of separation from the colchicine binding activity. However Eipper (72) and Shigekawa and Olsen (74) separated tubulin and the protein 9 kinase by gel filtration chromatography. Sloboda and co- workers (53) did likewise using sucrose gradient ultracen- trifugation. The method used to purify tubulin determined whether tubulin was itself phosphorylated by the associated protein kinase. Goodman and co-workers (73) using the Weisenberg procedure (8) obtained ig,zitgg.phosphorylation while Sloboda and co-workers (53) using the Shelanski method (28) did not see phosphorylation. Sloboda and co-workers (53) have also found cAMP dependent phosphorylation of HMW proteins which may be related to their role in microtubule structure and function. Rappaport and co-workers (75) achieved phosphorylation of MAP8 but found that an inhibitor of cAMP dependent protein kinase did not affect ig,zi§gg polymerization. They concluded that phosphorylation of MAPS did not affect microtubule assembly. Tubulin prepared by the polymerization-depolymerization method of Shelanski and co-workers (28) has been shown to contain other enzymatic activities. besides cAMP stimulated protein kinase. which may affect microtubule structure and function. Among these are a nucleosidediphosphate kinase activity (122). a diglyceride kinase activity (80). a phos- pholipase C activity (81). and a tubulin d-subunit tyros-r ylating activity (82). The inhibitory affect of colchicine on microtubule assembly has made it useful as a tool for studying the involvement of the microtubules in various cell processes. Microtubules have been implicated in the secretion or release 10 of substances by various cell types including insulin from.. the pancreas (77-79). thyroid hormone from the thyroid (83. 84). growth hormone from the pituitary (85). VLDL from the liver (86.92-94). protein from lacrimal glands (95). amylase from the pancreas (96). amylase from.the parotid gland (97. 98). glycoprotein from the salivary gland (99). catechola- mines from.the adrenal medulla (100.101). and lyscsomal enzymes from phagocytes (102-104). Colchicine did not seem to be poisoning other cellular functions such as glycolysis. gluconeogenesis. maintenance of energy charge. lipid bio- synthesis. protein synthesis. or urecgenesis so presumably its effects on secretion were solely due to microtubule disruption (86). Supporting this was the fact that inves- tigators correlated inhibition of secretion with microtubule disappearance (85.86.88.9l.96.98). Other evidence that colchicine effects were solely due to microtubule disruption was actual isolation of colchicine-tubulin complex and sim- ilarities in the time course of colchicine binding. micro- tubule disruption. and inhibition of secretion (78.84.85.95). The sequence of protein synthesis. intracellular trans- port. and secretion is well established. Proteins are syn- thesized on polysomes. attached to the membrane of the endo- plasmic reticulum. transported to the interior of the rough endoplasmic reticulum. then to the smooth endoplasmic reti- culum and finally to the Golgi apparatus. The Golgi appara- tus then migrates towards the cell membrane fuses with it and releases its contents. VLDL are also secreted via the ll Golgi-derived secretory vescicles. With the administration of colchicine. protein (92-94) and lipoprotein granules (87.90) accumulated in Golgi-derived secretory vescicles implying that colchicine was inhibiting the release of contents from.the Golgi. Chambert-Guerin and cosworkers (95) working with rat lacrimal glands suggested that colchicine inhibited the secretory processeby dis- turbing intracellular migration of secretory granules rather than by interfering with the discharge step. A weak and/or delayed inhibitory effect of high colchi- cine concentrations has been demonstrated on the secre- tory processes that follow hormonal stimulation (83.97) while the release of VLDL or other proteins was inhibited by low colchicine concentrations (86-88.92.94). The dif- ference between systems may be an indication of inherent differences in cell type. secretion processes. or micro- tubules. Recently Reaven and Reaven (105) have seen that an increase in VLDL secretion can occur without any demon- strable change in hepatocyte assembled microtubule or tubulin content and questioned whether microtubules are involved in hepatic VLDL secretion. Redman and co- workers (93) observed that colchicine inhibited protein synthesis in cells exposed for more than one hour and this inhibition affected both secretory and nonsecretory proteins. Investigators have also shown that colchicine concentrations which cause the virtual disappearance of microtubules gave only a 35-45% inhibition of release or 12 secretion (85,104,106). These observations imply that a change in tubulin content or polymerization may not be the controlling factor in these secretory processes. Speculations have been made that colchicine is affecting secretory processes by a mechanism independent of micro- tubules (91.105). To better understand the function and regulation of microtubules in the cells investigators have been looking at the subcellular distribution of the colchicine binding protein. Investigators have shown that a substantial a- mount of brain tubulin was in the particulate fraction of brain homogenates (15.107). Bhattacharyya and Wolff (108) found that in brain 45-50% of the total homogenate colchicine binding activity was in the cytoplasm while in the thyroid the percentage was 70-75. The remaining colchicine binding activity was associated with membrane bound tubulin. which on the basis of colchicine binding properties and immunological cross- reactivity resembled soluble tubulin. This solu- bilized membrane tubulin can polymerize to form micro- tubules (109). While colchicine binding activity in membrane containing brain fractions resembled that of soluble tubulin. colchicine binding activity in liver membrane containing fractions differed considerably from tubulin (110). Ninety-eight percent of the colchicine binding activity in platelets was in the soluble fraction rather than in membranes and granules (37). 13 In the islets of langerhans. colchicine binding activity was predominantly confined to the post microsomal super- natant fraction (105.000 g for 60 minutes) (78). The reason for the different distribution of colchicine binding activity in the various cell types is not known. In order to study microtubule regulation. in gig-9,. attempts were made to isolate the in,ziyg situation of polymerized and free tubulin. Koehn and Olsen (33) measured the forms of tubulin in brain by disassembling all microtubules to obtain the total tubulin content while determining free levels by homogenizing tissue in a glycerol-MES stabilizing buffer. centrifuging. and assaying tubulin in the supernatant. They found that the distribution of tubulin between the polymeric and free state varied with protein concentration. possibly due to ip_gitgg polymerization. This conclusion may be warranted because the tubulin concentrations studied were in the range of the critical concentration for polymerization of purified tubulin. iglyipgg. Rubin and Weiss (113) measured the extent of microtubule 389- sembly in ovary cells. by first disassembling micro- tubules with a cold buffer followed by colchicine binding to determine total tubulin content. Polymerized tubulin was measured by homogenizing cells in a glycerol buffer. pelleting the microtubules. resuspending the pellet to disassemble the microtubules. centrifuging. and assaying the supernatant for colchicine binding activity. The l4 assay was not sensitive to cold conditions but an in- crease in the percent of tubulin polymerized was seen with an increase in dibutryl cAMP. Patzelt and co- workers (114) were the first to characterize livers? tubulin. They measured the total microtubule content by depolymerizing microtubules in the cold in.the absence of glycerol. Free tubulin was measured by homogenizing tissue in a cold glycerol buffer. centrifuging. and [assaying the supernatant. The amount of tubulin polyp merized was 40% of the total. In comparison to 15$ which was attained by Reaven and co-workers (115) using a combined morphometric and biochemical approach to identify and quantitate microtubules. Pipeleers and co- workers (116) have also devised a method to assay poly- merized and free forms of tubulin. Liver tissue was homogenized in a glycerol-BMSO containing buffer and the homogenate centrifuged to pellet the intact micro- tubule. The supernatant was assayed for free tubulin using a colchicine binding assay. The pellet was re- suspended in a cold sucrose buffer to disassemble the intact microtubule. The suspension was centrifuged and the supernatant was assayed using a colchicine binding assay. The amount of total tubulin was the calculated sum.of the free and polymerized forms. The percent of total tubulin that was.in the polymerized form.wa8rv35. Eichhorn and Peterkofsky (106) measured total and poly; merized tubulin in 3T3 cells. To measure polymerized 15 tubulin. cells were sonicated in a glycerol-DMSO con- taining buffer. centrifuged to sediment the intact micro- tubules. pellet resuspended in cold phosphate-magnesium buffer with 0.5% triton x-1oo, sonicated. centrifuged. and the supernatant was assayed for colchicine binding activity. Total tubulin was measured by disrupting all microtubules into soluble tubulin by sonicaticn at 0‘0. Forty-seven percent of the total tubulin was polymerized. These proceeding methods basically use a glycerol buffer to stabilize the microtubule allowing for the separation of polymerized tubulin from free tubulin. Cold tem- peratures are used for their depolymerization affects. Finally a colchicine binding assay is used to quantitate tubulin. Investigators have looked at the influence of phys- iclogical states on tubulin content and polymerization. In pancreatic islets. during fasting total tubulin con- tent and the percent of tubulin polymerized was decreased compared to controls (11?). A 30% dextrose solution diet resulted in an increase in the percent of tubulin poly- mlrized over that of controls. This study supports the theory that tubulin polymerization is involved in the insulin secretory response to a glucose stimulus. In another study (118). starved rats showed a decrease in total liver tubulin and the percent of tubulin polymerized. Feeding rats a 30% dextrose solution diet increased the degree of liver tubulin polymerization over that of con- 16 trols without affecting the total tubulin content. Pipeleers and co-workers (118) found that the total tubulin content per DNA in the liver of genetically obese mice was increased over their lean litter mates in the fed state but in the fasted state tubulin content was the same. Genetically obese mice had a lower per- centage of their tubulin in the polymeric form in both fed and fasted conditions. Pipeleers and co-workers also looked at tubulin content and polymerization in lymphocytes and platelets (118). Phytohemagglutin- stimulated lymphocytes had an increase in total tubulin content over controls. The increase was due to an in- crease in polymerized tubulin. Storage of platelets re- sulted in a decrease in total tubulin and even greater reduction in the polymerized form. Normal values of the percentage of tubulin polymerized in these tissues were liver 30-35%. islets 35-40%. lymphocytes'V60%. and plateletsaV90%. From these studies it has been shown that total tubulin content and its degree of poly- merization can be modulated independently by a wide variety of physiological factors. The function of microtubules in the cell may be involved in their attachment to cell membrane compo- nents. Various studies have shown that local anesthetics interfere in microtubule function. possibly by depoly- merization of the microtubule (106). Recently in- vestigators have shown that these anesthetics do not l7 bind to tubulin or cause depolymerization though they may be involved by detaching microtubules from the cell membrane (106). Electron microscopy has shown that microtubules were absent immediately beneath the cell ‘membrane. Studies of “capping“ of various cell types in the presence of concanavaliaaA.and colchicine indicate that membrane proteins may be "anchored" in place by microtubules (120 . 121) . 9. 10. ll. 12. 13. l4. l5. l6. BIBLIOGRAPHY Inoue. S. (1964). Primitive Motile S stems ip Cell Biology. New York. Academic Press. Inc. 359. Inoue. S. and Sato. H. (1967). g;,Gen. ngsiol. 59. 259- Borisy. G. G. and Taylor. E. W. (1967). g; Cell Biology 33:. 535. Rosenbaum. J. L. and Child. F. M. (1967). J; Cell 3101051 it. 345 0 Biolog 35, 117A. Taylor. E. w. (1965). :1. 9.6.1.1 2.1.2.125! 22. 145- Borisy. G. G. and Taylor. E. W. (1967). g; Cell Biology 33.. 525. """" . Weisenberg. R. C.. Borisy. G. G.. and Taylor. E. W. (1968). Biochemistry z. 4466. Kirkpatrick. J. B.. Hyams. L.. Thomas. V. L.. and Howley. P. M. (1970). g; Cell Biology 41. 384. Wilson. L. and Meza. I. (1972). g; Cell Biology 58. 709. Wilson. L. and Bryan. J. (1974). Adv. Cell. Mol. Biol. 3. 21. Wilson. L.. Bamburg. J. R.. Mizel. S. B.. Gresham. L. R.. and Creswell. K. M. (1974). Fed. Proc. 31. 158. Borisy. G. G.. Olmsted. J. B.. Marcum. J. M.. and Allen. C. (1974). Fed, Proc. 33. 167. Margolis. R. L. and Wilson. L. (1977). Proc: Natl, Acad. sax... 15.4. 7.9.. 3466- """"' Wilson. L. (1970). Biochemistrng. 4999. ngfiwood. A. H. (1979). Proc. Natl. Acad. Sci. E§A7Zé. 18 l7. l8. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30- 31. 32. 33. 34. 35. 19“- Nunez. J.. Fellous. A.. Franccn. J.. and Lennon. A. M. (1979). Proc. Natl. Acad. Sci. USA ZQ. 86. giégon. L. and Friedkin. M. (1967). Biochemistry é. Borisy. G. G. (1972). Anal. My; 5_0_. 373. Sherline. P.. Bodwin. C. K.. and Kipnis. D. M. (1974). Anal. Biochem. 5;. 400. Weber. K.. Pollack. R.. and Bibring. T. (1975). Proc. Natl. Acad. Sci. USA-22. 459. Le Guern. C.. Pradelles. P.. and Dray. F. (1977). FEBS Letters 281;. 97. Karsenti. B.. Guilbert. B.. Bornens. M.. and Avrameas. S. (1977). Proc. Natl. Acad. Sci. USA IE; 399?. Brinkley. B. R.. Fuller. G. M.. and Highfield. D. P. (1975). Proc. Natl. Acad, Sci. USA 1;. 4981. Kirschner. M. W.. Honig. L. S.. and Williams. R. C. (1975). g; Mol. Biol. 22. 263. Weisenberg. R. C. (1972). Science 1 . 1104. Bigésy. G. G. and Olmsted. J. B. (1972). Science 111. Shelanski. M. L.. Gaskin. P.. and Cantor. C. R. (1973). Proc. Natl. Acad. Sci. USA Zé. 765. Olmsted. J. B. and Borisy. G. G. (1973). Biochemistry Olmsted. J. B. and Borisy. G. G. (1975). Biochemistry lit 29960 Gaskin. P.. Cantor. C. R.. and Shelanski. M. L. (1974). g; M01. Biol. §2. 737 Bamburg. J. R.. Shooter. E. M.. and Wilson. L. (1973). Biochemistry 12. 1476. Koehn. J. A. and Olsen. R. W. (1978). Arch. Biochem, Biophys. 186. 114. Castle. A. G. and Crawford. N. (1975). FEBS Letters filo 195- Castle. A. G. and Crawford. N. (1977). Biochim. Biophys. Acta 424. 76. 36. 37. 38. 39. 40. 41. 42. 43. an. 45. 46. 47. 48. 49. 50. 51. 52. 53. 20 Ikeda. Y. and Steiner. M. (1979). g; Biol. Chem. 32%. 66. Castle. A. G. and Crawford. N. (1978). Thrombos Haemostas 22. 386. Barnes. L. D.. Engel. A. G.. and Dousa. T. P. (1975). Biochim. Biopgys. Acta 40 05. 422. Green. L. R.. Brandis. J. W.. Turner. F. R.. and Raff. A. (1975). Biochemistry 14. 4487. Doenges. K. H.. Nagle. B. W.. Uhlmann. A.. and Bryan. J. (1977). Biochemistry 16.3455. Weatherbeev J- Ao: Luftig. R. B.. and Weihing. R. R. (1978). J. Cell Biol. 8, 47 Bulinski. J. C. and Borisy. G. G. (1979). Proc. Natl. Acad. Sci. USA zé. 293. Shelanski. H. L. and Taylor. E. W. (1968) 11 Cell Biol. 18. 304. §ogayashi. T. and Simizu. T. (1976). g1 Biochem. 12. 3 7. Arai. T. and Kaziro.Y .(1977).J . Biochem. 82.1063. Jacobs. M. and Caplow. M. (1976). Biochem. Bioggys. Res. Commun. 68. 127. . Weisenberg. R. C.. Deery. W. J.. Dickinson. 0. J. (1976). Biochemistry _§. 4248. Arai. T. and Kaziro. Y. (1976). Biochem. Bioghys. Res Commun. _2. 369. Weisenberg. R. C. and Deery. W. J. (1976). Nature 26 , 792. Burns. R. G. and Pollard. T. D. (1974). FEBS Letters £9. 274. Murphy. D. B. and Brown. G. G. (1975). Proc. Natl, Acad. Sci, USA 1;. 2696. Weingarten. M. D.. Lockwood. A. H.. Hwo. S. Y.. and 1;, 2858. “""""""""“"“" Sloboda. R. D.. Rudolph. S. A.. Rosenbaum. J. L.. and Greengard. P. (1975). Free» Natl. Acad. Sci. USA 72. 177. ""“""' 55. 56. 57. 58. 59. 60. 61. 62. 63. 65. 66. 67. 68. 69. 70. 71. 21 Olmsted. J. B. and Borisy. G. G. (1973). Annual Review of Biochemistgx 42, 507. Kim. B.. Binder. L. J.. and Rosenbaum. J. L. (1979).J Cell Biol. 80,266. '4 Murphy, D. B.. Vallee. R. B.. Borisy. G. G. (1977). W 11.2598. Sloboda, R. D.. Dentler. W. L..~and‘Rosenbaum, J. L. (1976). BiochemistrxS1j, 4487. Herzog, w. and Weber. K. (1978), Eur. g, Biochem. 2g. 1. Herzo . W. and Weber. K. (1977), Proc, Natl. Acad, Sci, USA 2...- 1860. Rimes. R. R.. Burton. P. R.. Kensey. R. N.. and Pierson, G. B. (1976 ), Proc, Natl, Acad Sci. USA 12, 4397. Dentler. W. L.. Granett. S.. and Rosenbaum. J. L. (1975). ,1, Cell Biol. g1, 23?. Smith, D. S.. Jarlfors. U.. and Cameron. B. F. (1975), Ann, 3, z,,Acad, Sci. 252, 472. Sherline. P.. Lee. Y.-C., and Jacobs, L. S. (1977). J, Cell Biol, 2;, 380. Witman. G. B.. ”Cleveland. D. W.. Weingarten. M. D.. and Kirszhner. M. .(1976). Proc, Natl, Acad, sci, USA 22. 070 Cleveland, D. W., HWo, S. Y.. and Kirschner. M. W. (1977). g,,Mol, Biol, 116, 207. Cleveland, D. W., Hwo. S. Y.. and Kirschner. M. W. (1977). 1.111111211119227. Connolly. J.. Kalnlns, V. 1.. Cleveland. D. W.. and Kirschner, M.W . (1977). Proc, Natl, Acad,-Sci, USA. 2.42 437. Vallee. R. B. and Borisy. G. G. (1978), J. Biol. Chem. 253, 2834. "'" _- Sheele. R. B. and Borisy, G. G. (1976). Biochem, Bioghxs, Res, Commun. 29. l. Scifer. D. (1975), g, Neurochem, g2, 21. Kirschner. M. W., Williams, R. G.. Weingarten. M.. and Gerhart. J. .(1974). Proc, Natl, Acad. Sci USA 23,, 1159. 72. 73- 74. 75- 76. 77. 78. 79. 80. 81. 82. 83. 84. 850 86. 87. 88. 22 Eipper, B. A. (1974), g; Biol. Chem. gig. 1398. Goodman, D. B. P.. Rasmussen, R.. Dibella, P.. and Guthrow, C. E. (1970), Proc. Natl. Acad. Sci. USA @652. —____ Shigekawa, B. L. and Olsen. R. W. (1975) Biochem. Bioghxs. Res. Commun. 91, 455. , Rappa ort, L.. Leterrier, J. P.. Virion, A.. and Nunez, J. (1976 , Eur. J; Biochem. ég, 539. Klein, 1., Willingham, M.. and Pastan, I. (1978), Experimental Cell Research 114, 229. P. E.. Howell. S. L.. Young, D. A.. and Fink. C. J. (1968), Nature (Mnd0n2212, 1177. Montague, W., Howell, S. L.. and Green. I. C. (1975). , Biochem. g. 148. 237. ; Malaisse, W. J.. Malaisse-Lage, P.. Van Oblerghen, E., Somers, G.. Davis, G.. Ravazzola, M.. and Orci. L. (1975), Ann, g. g. Acad. Sci. 253, 630. Daleo. G. R.. Piras, M. M.. and Piras, R. (1974). Biochem. Bio 5. Res, Commun, 61, 1043. Quinn, P. J. (1973), Biochem. g; 122, 273. Raybin, D. and Flavin, M. (1977), Biochem. Biophxs. Res. Commmun. _5,1088. Wolff, J. and Williams, J. A. (1973), Recent Pro ess Hormone Research 22, 2 9. Williams, J. A. and Wolff, J. (1972), J. Cell Biol. Sheterline. P.. Schofield, J. G.. and Mira. F. (1975), BiochemI g; 148. 35. Le Marohand. Y., Singh, A.. Assimacopoulos-Jeannet. F5. Orci, L.. Rouiller. C.. and Jeanrenaud. B. (197 3), g. Biol, Chem2 248, 6862. Stein, 0. and Stein. Y. (1973), Biochim. Biophxs, Acta 29..142- Orci, L.. Le Marchand, Y., Singh, A.. Assimacogoulos- l Jeannet, F., Rouiller, C., and Jeanrenaud.B 973). Nature 244, 30. 89.- 90. 91. 92. 93- 94. 95. 96. 97. 98. 99. 100. 101. 102. 103. 104. 105. 106. 23 Stein. 0.. Sanger. L.. and Stein. Y. (1974), g._Cell Biol. fig. 90. Sin h. A.. Le Marchand. Y.. Orci. L.. and Jeanrenaud, E. %1975). Eur. g. Clin. Invest, 5. 495. 'Reaven. E. P. and Reaven. G. M. (1977). J; Cell Biol. 2:0 559 o Redman. C. M.. Banerjee. D.. Howell, R.. and Palade, G. E. (1975), g. Cell Biol. gg. 42. Redman. C. M.. Banerjee. D.. Manning. 0.. Huang. C. Y.. Green. K. (1978). J. Cell Biol. 22, 400. Le Marchand. Y.. Patzelt. G.. Assimacopoulos-Jeannet. P.. Rouiller. 0.. and Jeanrenaud. B. (1974). J. Clin, Invest. 51, 1512. Chambaut-Guerin. A. M.. Muller. P.. and Rossignol. B. (1978). g. Biol. Chem, 253. 3870. Wééliams. J. A. and Lee. 14. (1976). .1. Cell Biol, 2_1_. 7 . Butcher. F. R. and Goldman, R. H. (1972). Biochem. Bioghxs. Res, Communl fig. 23. Patzelt. C.. Brown. D.. and Jeanronaud. B. (1977). LQELLEiLlLD. 578. Rossignol. B.. Herman. G.. and Keryer. G. (1972). FEBS Letters 21, 189. Poisner. A. M. and Cooke, P. (1975). Ann, 3. I; Acad. Sci, 251. 653. Poisner. A. M. and Bernstein. J. (1971). g. Pharmacol. Exp, Ther, 111, 102. Zurier. R. B.. Hoffstein. S.. and Weissmann G. (1973). 1.9511211115127. Zurier. R. B.. Weissmann. G.. Hoffstein. 8.. Kammerman. S.. and Tai. H. H. (1974). £4,011n. Invest, 51. 297. Hoffstein. S.. Goldstein. I. M.. and Weissmann. G. (1977). g. Cell Biol. 21, 242. Reaven. E. P. and Reaven. G. M. (1978). J. Cell Biol. 22. 735. Eichhgrn. J. H. and Peterkofsky. B. (1979). g. Cell Biol, .142- 107. 108. 109. 110 . 111. 112. 113. 114. 115. 116. 117. 118. 119. 120. 121. 122. 123. 124. 24 Dahl. D. R.. Redburn. D. A.. and Samson. P. E. (1970). .J_. 2; Neurochem, 11. 1215. Bhattacharyya B. and Wolff J. (1975) ‘g. Biol Chem 52. 7639. ' ' ' ""'"“"'"" Bhattacharyya. B. and Wolff. J. (1976). Nature‘géfi. 576. Stadler. J. and Franks. W. W. (1973). g. Cell Biol. .62. 297. Goldstein. M. A. and Entman. M. L. (1979). g. Cell Biol, 89, 183. Frankel. P. R.. Tucker. R. W.. Bruce. J.. and Steinberg. R. (1978). g. Cell Biol, 22, 401. 22b13. R. W. and Weiss. G. D. (1975). g. Cell Biol. 2 __J . Patzelt. 0.. Singh. A.. Le Marchand. Y.. Oroi. L.. and Jeanrenaud. B. (1975). g._Cell BiolI 66. 609. Reaven. E. P.. Cheng. Y.. and Miller. M. D. (1977). g. Cell Biol. 25. 731. Pipeleers. D. G.. Pipeleers-Marichal. M. A.. Sherline. P.. and Kipnis. D. M. (1977). g. Cell Biol, 24. 341. Pipeleers. D. G.. Pipeleers-Marichal. M. A.. and Kipnis. D. M. (1976). Science 12;. 88. Pipeleers. D. G.. Pipeleers-Marichal. M. A.. and Kipnis. D. M. (1977). g. Cell Bio;I 24. 351. Sherline. P. and Schiavone. K. (1977). Science 128. 1038. Edelman. G.. Yahara. 1.. and Wang. J. L. (1975). Proc. NatlI Acad. Sci. USA 29, 1442. Albertini D. F. and Clark J. I. (1975) Proc Natl Acad, Sci; g§_A_ 2;, 4976. ' ' —""'" """' Nickerson. J. A. and Wells. W. W. (1978). Biochem. Bioghxs. Res. Commun. 85. 820. Snyder. J. A. and McIntosh. J. R. (1976). Ann. Rev. Biochem. ii. 699- Borisy. G. G.. Marcum. J. M.. Olmsted. J. B.. Murphy, D. B.. and Johnson. K. A. (1975). Ann. N‘_Z&.Acad. Sci. £5.29 107 o 25 125. Weisenberg. R. C. and Timasheff. S. N. (1973). Biochemistgz 2, 4110. 126. Lee, J. 0.. Frignon. R. P.. and Timesheff. S. N. (1973). g. BiolI Chem. 248. 7253.‘ 127. Sandoval. I. V. and Cuatrecasas. P. (1978). Eur. g.‘Biochem. 21. 151. 128. Ostlund. R. and Pastan. I. (1975). Biochemistg: 11;, 4064. 129. Sherline. P.. Schiavone. R.. and Brocato. S. (1979). Science 225. 593. CHAPTER I TUBULIN CONTENT AND POLYMERIZATION IN THE STARVED-REFED RAT LIVER ABSTRACT The regulation of liver tubulin content and polymeri- zation. ig_zizg. is not well characterized. By looking at a system where these features can be experimentally manipu- lated, a better understanding of tubulin regulation may be attained. Accordingly. young male rats of the Holtzman strain were starved for 3 days and rated a high-glucose con- taining diet. At intervals during the 48 hour rereading period. rats were killed and the liver was assayed for free and polymerized tubulin (1). After‘j days starvation. plasma glucose and insulin levels were decreased and liver any? and cGMP levels were elevated compared with fed controls. Following refeeding. plasma glucose and insulin levels rap- idly increased reaching a peak at 6 hours for glucose and 1 hour for insulin. though the latter did not exceed those of control rats. Liver CAMP levels decreased in the refed rats to those of normal rats by 3 hours,_while liver cGMP levels decreased below control levels and did not approach 26* 27 control levels until 36 hours after refeeding. Starved rats showed a significant decrease in both free and polymerized liver tubulin. Eighteen hours after refeeding. the level of liver polymerized tubulin approached control levels. while the free tubulin levels failed to increase throughout the 48 hours. The degree of tubulin polymerization was de- pressed during starvation and increased significantly after refeeding to values above those of controls. INTRODUCTION In this study. the starved-refed rat liver was used to study regulation of tubulin content and in 1112 polymeriza- tion. It has long been recognized that liver function is hormonally regulated. During starvation of the rat. plasma glucose and insulin levels decrease and plasma glucagon levels increase. In the liver. the rates of glycolysis. protein synthesis. lipogenesis and lipoprotein secretion decrease while the rates of gluconeogenesis and fatty acid ‘ig-oxidation are greatly increased (3.4). Liver cAMP concen- trations are increased during starvation but a controversy regarding cGMP levels remains (5.6.7). Refeeding starved rats a diet rich in glucose causes an increase in plasma glucose and insulin levels and a de- crease in glucagon concentrations. After refeeding. the rates of protein synthesis. lipogenesis. and lipoprotein release increase in the liver (8.9.10). Microtubules are thought to be involved in and required for the secretion of VLDL 28 and plasma proteins from the liver (ll-18.44). Therefore. this system. in which the secretory processes can be manip- ulated. is one in which the regulation of microtubule func- tion might profitably be studied. Preparations of microtubule protein contain a cyclic AMP dependent protein kinase which can phosphorylate tubulin and MAPs (19). Cyclic AMP dependent phosphorylation of microtubule components may play a role in microtubule assem- bly or function 12.1122 (19.20). Reciprocal effects of cAMP and cGMP on the microtubule-dependent release of lysosomal enzymes from polymorphonuclear leukocytes have been found (21.23). It is possible that cyclic nucleotides affect secretory processes via an effect on microtubules. In this study we were able to manipulate many physio- logical variables in the rat by starving and refeeding. By measuring liver tubulin levels and the degree of tubulin polymerization we could try to correlate physiological variables with microtubule assembly in;zizg. .Among the physiological variables measured were plasma glucose and insulin levels. and liver cyclic nucleotide levels. MATERIALS AND METHODS Animal Treatment. Male Roltzman rats weighing approximately 180 grams were housed in groups of 3 or 4 in plastic cages containing wood chips. All animals were housed in an air- conditioned room at 23°C under controlled lighting (lights 6 A.M.-6 P.M.). A control group was fed a commercial chow 29 and water. ad libitum. throughout the experiment. Animals were starved for 3 days with free access to water and refed a high-glucose containing diet. 20% casein. 68.9% glucose monohydrate. 5% corn oil. 5%‘Wesson salt mixture. 0.1% choline chloride. and 1% vitamin mixture (24). Samplg Prepgggtion.£gg Tubulinwggggy. Rats were killed by decapitation. Livers were excised and quickly immersed in MTS buffer containing 50% glycerol. 5% DMSO. 1.0 mM GTP.*+- 0.5 mM MgClz. 0.5 mM EGTA. in 10 mM phosphate buffer pH 6.95 and immediately homogenized with a loosely fitting Teflon pestle (l). The homogenate was centrifuged (to pellet the microtubules) at 40.000 rpm for 45 minutes at 30°C. The amount of free tubulin in the supernatant fraction (SN 1) was measured by a colchicine binding assay (25). The pellet was resuspended in ice-cold TS buffer containing 0.25 M sucrose. 0.5 mM MgClz. 1.0 mM GTP in lOmM phosphate buffer pH 6.95 and centrifuged at 40.000 rpm for 30 minutes at 4°C. The supernatant (SN II) was assayed for tubulin (original polymerized tubulin) by a colchicine binding assay (Figure I). Colchicine Binding.5§§gy. Colchicine binding activity was determined using a modification of Pipeleers and co-workers (1) method. Aliquots (100 ad) of the supernatant fractions were incubated with 25.nl of a 40.uM 3H-colchicine solution (0.25 Ci/mmole) at 37°C for 3 hours when MTS was used and 1 hour when TS was used. A 5 mg/ml charcoal in water sus- pension (500 ml) was then added. to adsorb the free colchi- cine. The suspension was mixed thoroughly. allowed to settle 30 Figure I: Rats were sacrificed and livers were removed. A piece of liver was homogenized in MTS buffer and centrifuged. The supernatant was assayed for free tubulin using a colchicine binding assay. The pellet was resuspended in TS buffer (cold) and centrifuged. The supernatant was assayed for tubulin (original polymerized tubulin) using a colchicine binding assay. 31 TUBULIN ASSAYl PE. ham. --- Homogenate { Pellet resuspend In TS but. at 0° for IS min. ‘ lO0,000xg . 0°, 30min. Pellet Supernate discard V [attJ-colchicine incubate lhr.,37° V * activated charcoal count aliquot of supernate jPOLYME RlZEDl ' in MTS but. Liver ' % centrifuge, l,OOOxg, count aliquot ofsupernate Ioo ,OOOxg 30", 45min. Supernate [3H]"'colchicine“r incubate 3hrs.,37° V activated charcoal V ’. 5min. IFREEI centrifuge,l,000xg,5min. I 0.0.PIPELEERS.OQOI.(I977) J. Cell Biol. 74.34I'350 *EH} colchicine=8.0uMl _ 2.5on” uCi/mmol. ‘ Figure I: H Protocol Used for Determining the Amount of Free and '- Palymerized Tubulin in the Starved-Refed Rat Liver. 32 for 5 minutes. then centrifuged for 5 minutes. A 500‘pl aliquot of the supernatant was added to 9 ml of Brays scin- tillation cocktail (26) and radioactivity detected in a Beckman Liquid Scintillation System. Colchicine binding activity was converted to tubulin equivalents by assuming a 1:1 molar ratio of colchicine binding to tubulin and a molecular weight for tubulin of 110.000 (27). The colchi- cine binding activity was measured in SN I and SN II to quantitate respectively the amount of tubulin originally present in the free and polymerized forms (Figure 1). Protein Determination. Liver tissue was homogenized in phosphate buffered saline and protein concentration was determined by the method of Lowry and co-workers (28) which was modified for automated analysis as described by Mak and Wells (24). DNA Determination. DNA content was measured in liver homo- genates (phosphate buffered saline) by the Ethidium Bromide method as described by Kurtz and Wells (29). Sample Prepggation Egg Glucose. Insulin. and Cyclic Nucleotides. Rats were ether-anesthetized and a hepari- nized syringe was used in cardiac puncture to collect blood for glucose and insulin analysis. Livers were quick frozen between stainless steel tongs cooled in liquid nitrogen. The tissue was later used to measure cyclic nucleotides. Glucose Determinations. Plasma glucose was determined by using the Computer-Directed Gilford 3500 Analyzer and the Gilford/Worthington reagent glucose kits. 33 Insulin Determination. An Insulin Radioimmunoassay kit (Amersham..Arlington Hts. Illinois) was used to measure plasma insulin. ngl 2 Nucleotide Determinations. Freeze clamped liver samples were deproteinized by TCA extractions. TCA was then.removed by extractions with water-saturated other. cAMP and cGMP Radioimmunoassay kits (Amersham..Arlington Hts. Illinois) were used to measure cyclic nucleotides levels. Colchicine Binding Qggzgg. Male Holtzman rats weighing ”250 grams were decapitated and livers were removed. See §amplg Preparation {23 Tubulin.£§§gy and Colchicine Binding Agggy_for methods of measuring free and polymerized tubulin by the colchicine binding assay. Modifications of the col- chicine binding assay were: SN 1 incubated with 3H-colchi- cine for 5 hours and SN II incubated with 3H-colchicine for 3 hours. every 15 minutes samples were assayed for colchicine binding activity. Statistics. Statistical Analyses were performed using the two-tailed t-test (35). RESULTS In order to use the colchicine binding assay quanti- tatively. experiments were done to determine. in both buffers. the time at which maximum.binding of colchicine to tubulin occurred. Figure II indicates maximum binding of colchicine in MTS (glycerol-DMSO buffer) occurs after Figure II: MTS and TS samples were incubated with H-colchicine. At time intervals aliquots were assayed for colchicine binding activity. Colchicine binding activity is expressed as a percent of maximal binding. 35 wk DZ< m...<< Z. >._._>_._.U< 02.02_m uZ_U_IU._OU ".0 mU_._.mZ_v_ u: memu: mthZ_<< oom CNN ova O—N 02 05 ON— 00 00 on _ _ _ a _ _ _ _ _ _ oNlaNIs aNIDIHo'Ioo % 36 3 hours and in TS (sucrose buffer) after 1 hour. To analyze liver cyclic nucleotide levels accurately. the liver was quick frozen by freeze clamping. Rats used for cyclic nucleotide analysis were other anesthesized and heart puncture was performed.on them to collect blood for glucose and insulin analysis. Ether anesthesia may interfere with tubulin polymerization andfreeze clamping the liver may interfere with the tubulin analysis. so a- nother set of rats (which were treated similarly to the ether anesthesized rats) were decapitated and used for the tubulin assay. Even though the data in Table I is from the decapitated rats. it is a fair representation for both sets of rats. Protein and DNA levels were measured in order to ex- press tubulin content in terms of these parameters. Also. by measuring liver protein and DNA content the effects of starving and refeeding on these parameters could be ob- . served. The amount of protein per liver is decreased during starvation and increased to normal levels by 6 hours after refeeding (Table II). As seen in Table II. the DNA content of liver appears to increase with re- feeding contrary to earlier reports which state that DNA content does not change with dietary state in an adult rat (30.31). This reproducible increase may be a growth phenomenon or an artifact of the Ethidium Bromide Assay. In the liver of young adult mammals. most liver cells are binucleated (34). Many liver cells. therefore are 37 Table I: Male Holtzman rats were starved for 3 days and then refed a high glucose diet. Each value is the mean 1 standard deviation of 3 animals. 38 m.ma as. w 50.: ea w mam .mus we o.~n ma. w mo.: m n mad .ma: on m.a~ wm.a fl am.: m n mod .mas em m.ea «o. H om.s as H com .mas ma a.sa mm. u am.n o n mom .mas ma «.0 am. u ma.n mm H one .mas o m.n no. u oo.m me u and .ma: n m.H 3N. h om.N w H “ma .9: H 0 ma. u mn.m ma w and mas» o I. as. u mn.n me n mum pone souusoso Amy pom ham sopam Asmmooa\msaawv va pawn wsauoomom pawn omaao>< passe; oo>fig passe: seam aspu< mane wean mucosao swam m couom spam uo>uupm Ho unawaoz no>wg was keen use soavassmsoo coon H mqmuapm 2“ ag HH mqmHA Pam somomuuo>uuvm on» ma swopoam mom :«asnsa Ho Hssos< ess nowadaduoshaom seasnss Ho nonwoa one HHH mqm<9 44 Figure III: Liver Free and Polymerized Tubulin and the Degree of Tubulin Polymerization in the Starved-Refed Rat. Each value is the mean 1 standard deviation of 3 rats. III- Significantly different from control values at P<.05. 45 pengeuMIod % wt «.92: ozEmwmwm mm...m< MEI. m_ N. m N¢ mm Om .VN saoaooEmk o zo:.<>m<5 N _ ueNtoEboa mm>_._ .._<._.O._. zo Qmm_u_ ._.m<._.m m N _ o O _ _ _ _ _ _ _ m ..../.H\ /\ueNtoE>_oa <20 20 Qmm3 ._.m<._.m m N _ O _ _ _ _ _ _ _ _ _ _ _ q I! : \ “”2200 EL a a w r x / \W\ \\ u \ x \H as?» \x m x x k\ mmo_._.0m:032 030>0 mm>_n_ ._. cheap you censuses one; swamps» mouaaosma°q was seam and .mss we was m.~ s“ couasomcso: one: me>aa Ho mvssoss vsouemhan .ma was was ma hvd>fipo< msavsam 050238 no 333:3 2:. :6 nemesis 2:32. so, esteem 9; .H 933a was so was n.m\ao>3 .8 ems con 8: com com _ _ _ _ l 3 I. om Imp I on Je;;ng go tnypunog eutotqotoo JO setomn 68 msmu me: e .H onsMHm Ga copamomov as case em» as: escapaema .ma use was as apa>apo< mcaesam oneoagoaoo mo synagogue on» so campuses .smaea mo scones one .HH assess was he was m.m\ao>ag me am: con 8: com com 03 _ _ _ _ _ xeyyng JO In/punog eutotqotoo JO setomn 69 large tissue to MTS ratio. colchicine binds to a constant amount of tubulin independent of the amount of tubulin. Liver or brain was homogenized in cold PBS to dis- assemble microtubules. The homogenate was centrifuged and the supernatant was diluted with MTS or TS 2:1 for liver samples and 5:1 for brain. To determine if either buffer was inhibiting the binding reaction of colchicine to tubulin. colchicine binding activities in both buffers were plotted vs.tubulin concentration. Figure III in- dicates that the colchicine binding activity is propor- tional to tubulin concentration in MTS and TS. The a- mount of tubulin in both MTS and TS is theoretically the same and Figure III supports this experimentally. showing that neither buffer is inhibiting the colchicine binding activity of tubulin. MTS and TS should contain the same amount of brain tubulin but as seen in Figure IV less colchicine binding activity is found in the MTS samples. Therefore. in brain preparations MTS has an inhibitory effect on the colchicine binding activity. Ip pippg polymerization studies indicate that in the presence of tubulin concentrations of 600 ug/ml (Figure V) or 1200 ug/ml (not shown). MTS will not promote assembly of microtubules. This is supportive evidence that MTS (glycerol-DMSO buffer) is not causing Lg zippg polymeriza- tion in our ip vivo studies. Colchicine Bound (0PM) 12000 10000 8000 6000 #000 2000 70 .— l J l 1 l 20 no 60 80 100 ml of Diluted Supernatant Figure III: Colchicine Binding of Liver Tubulin in MTS or TS. Liver was home— genized in cold PBS to disassemble micro- tubules. The homogenate was centrifuged and the supernatant was diluted with TS or MTS. Aliquots of the diluted super- natants were assayed for colchicine binding activity. © MTS s TS Colchicine Bound (CPM) 20000 16000 12000 8000 __ #000 71 _- l I l J | 20 #0 60 80 100 ml of Diluted Supernatant Figure IV: Colchicine Binding of Brain Tubulin in MTS or TS. Brain was home- genized in cold PBS to disassemble micro- tubules. The homogenate was centrifuged and the supernatant was diluted with TS or MTS. Aliquots of the diluted super- natants were assayed for colchicine binding activity. C] MTS 0T5 OD350 0.10 0.08 0.06 0.04 0.02 72 Figure V: Time in Minutes In V tro Polymerization Studies Using M S Buffer and Assembly Buffer with a Tubulin Concentration of 600 ug/ml. A Assembly Buffer B 600 lug/ml Tubulin in MTS C 600 .ug/ml Tubulin in Assembly Buffer with lmM GTP 73 DISCUSSION Colchicine binding activity was not proportional to tissue concentration in the HTS fractions. MTS may in- terfere with the separation of free tubulin from micro- tubules at high tissue concentrations and. therefore. lower values of colchicine binding activity would be seen in the MTS fractions. MTS because of its high glycerol content may be causing gp yippg polymerization at these high tissue concentrations. Figure V indicates that MTS did not allow ;2 zippg polymerization at tubulin concen- trations of 600 ug/ml. a concentration far above that seen in our ip vivo studies. This suggested that ip vitro poly- merization was not occurring in MTS during our gp pipe studies. If either of the two possible mechanisms men- tioned above were occurring. at high tissue concentrations the amount of polymerized tubulin should be increased. The sum of free and polymerized tubulin would be the same at all tissue dilutions but the distribution of tubulin between forms would be different. This was not the case. There was a decrease in measured total tubulin and an in- crease in the percent of total tubulin that was poly~ merized, which could be completely accounted for by a de- crease in the measured concentration of free tubulin. It appeared as if colchicine was not binding to all the tubulin in the MTS fractions at high tissue concentrations. The ability of colchicine to bind large amounts of tubulin 7# in the presence of MTS is seen in Figure III. therefore indicating MTS (glycerol-DMSO buffer) was not interfering with the colchicine-tubulin binding reaction. We are speculating that at high tissue concentrations. other factors in the tissue besides tubulin are also more lconcentrated and may be interfering with the colchicine binding assay. Possibilities are proteases or esterases which may destroy the tubulin molecule or the tubulin- colchicine complex. Investigators have recently re- ported endogenous protein molecules bind tubulin at the colchicine binding site (8.9.11). These endogenous mole- cules may be binding tubulin and inhibiting colchicine binding. If the colchicine binding incubation in MTS was prolonged. when using high tissue concentrations. more colchicine binding activity was detected. If the MTS fraction (free tubulin) was diluted with 320 or TS. the binding of colchicine to tubulin proceeded at a faster rate. The greater dilution or longer time period may enhance tubulin binding to colchicine relative to binding to endogenous proteins. , Recently. Ostlund and co-workers (10) investigated Pipeleers and co-workers' method (1) and demonstrated that glycerol and DMSO were responsible for apparent reduced affinity of colchicine binding in MTS. when colchicine concentrations of less than 20 uM were used. At larger colchicine concentrations the effects of glycerol and DMSO seem to be circumvented. 0stlund and co-workers 75 (10) suggested that glycerol-DMSO was competing with colchicine to bind tubulin. therefore a higher concen- tration of colchicine was needed to counteract the gly- cerol-tubulin reaction. Figure III would seem to indi- cate that MTS (glycerol-DMSO buffer) was not interfering with colchicine binding to tubulin. but one has to recall the sample was diluted 2:1 (MTS:PBS). therefore the PBS may be diluting the glycerol-DMSO. Ostlund and co-workers (10) have also shown that the reduced colchicine binding in MTS can be remedied by diluting the MTS. If we con- sider Ostlund and co-workers (10) results when interpreting our results then the nonlinearity of colchicine binding activity in MTS with respect to tissue concentration may indicate a need for a higher colchicine concentration at the higher tissue concentration (tubulin concentration) to compete with the glycerol-tubulin reaction. In con- clusion. even though we have presented two interpretations to explain the reduced affinity of colchicine binding in MTS. more work is needed to fully explain the phenomenon i. e.. isolating the endogenous inhibitors or finding glycerol or DMSO bound to tubulin in a way in which in- hibits the colchicine binding activity. It also should be noted that the reduced colchicine binding activity in the higher tissue concentrations may be due to increased protease or esterase activity. 10. 11. BIBLIOGRAPHY Pipeleers. D. G.. Pipeleers-Marchial. M. A.. . Sherline. P.. and Kipnis. D. M. (1977). J Ce llB Biol, LET-Fl. Murphy. D. B.. Vallee. R. B.. and Borisy. G. G. (1977). Biochemistry 16. 2598. Koehn. J. A. and Olsen. R. W. (1978). Arch. Biochem. Bio Rhys . 186’ ll“. Gaskin. F.. Cantor. C. R.. and Shelanski. M. L. (l97#). ._I_. Mol, Biol. 82. 737. Detrich III. H. W.. Berkowitz. S. A.. Kim. H.. and gillizm. R. C. (1976). Biochem. Biophys. Res. Commun. _§. 9 l. _ Eichhorn. J. H. and Peterkofsky. B. (1979). g, Cell Biol. 8;, 26. Nickerson. J. A. and Wells. W. W. (1978). Biochem. Biophys. Res. Commun. 85. 820. Nunez. J.. Fellous. A.. Franccn. J.. and Lennon. M. (1979). Proc. Natl. Acad. Sci. USA 16. 86. 118#. Ostlund.R . E.. Leung J. T.. and 5Vaerewyck Hajek. S. (1979). Analytical Biochem, 2_.15. Sherline. P.. Schiavone. H.. and Brocato. S. (1979). Science 295. 593. 76 CHAPTER III LIVER TUBULIN CONTENT AND POLYMERIZATION IN THE STREPTOZOTOCIN INDUCED DIABETIC RAT ABSTRACT The streptozotocin induced diabetic rat was used as a model to study microtubule regulation. The method of Pipeleers and co-workers (1) was used to measure free and polymerized tubulin in streptozotocin induced diabetic rats before and after insulin injections. A significant decrease in the degree of polymerization was observed in diabetic rats compared to control rats. Twenty four hours after a single insulin injection. the percent of total tubulin that was polymerized tubulin increased significantly over that of controls and diabetics. The free form of tubulin was elevated in diabetic rats but after an insulin injection decreased to control values. The change in total tubulin concentration closely paral- leled that of the free form, while the concentration of polymerized tubulin remained unchanged throughout the experiment. Plasma glucose and insulin levels confirmed earlier reports concerning diabetic and insulin treated rats. 77 78 INTRODUCTION The starved-refed rat model system demonstrated that the distribution of tubulin between the polymerizad and depolymerized forms may be modulated by physiological factors. The diabetic rat. before and after insulin in- jections, is another system in which physiological fac- tors may be manipulated and corresponding changes in tubulin content and polymerization studied. During diabetes hepatic gluconeogenesis and cAMP levels increase and protein content, albumin synthesis and secretion, and cGMP levels decrease (2,3,24,33). Plasma glucose levels increase and insulin levels decrease (5.6). Injecting insulin into diabetic rats results in a reversal of the effects of diabetes. i.e. decrease in plasma glucose levels and an increase in plasma insulin levels. In- sulin mediates an increase in the rates of glycolysis. the citric acid cycle. and fatty acid biosynthesis while decreasing hepatic cAMP levels, hepatic long-chain acyl CoA levels and serum free fatty acids (7). Insulin has been shown to stimulate hepatic lipogensis (8-14) and may increase triglyceride secretion from the liver (l#-16). Treatment of diabetic rats with insulin has been shown to restore rates of synthesis and secretion of albumin in the liver (24.33). An extensive amount of research supports the theory that microtubules are involved in the secretion of VLDL and plasma proteins from the liver (34- 38,40-42). In view of the link between hepatic VLDL 79 and plasma protein synthesis and secretion and the diabe- tic. insulin treated rat and the link between VLDL and plasma protein secretion and microtubules. we studied the effect of streptozotocin induced diabetes (insulin treated) on microtubule polymerization. We used streptozotocin to induce diabetes in our rats. Streptozotocin, N-methylnitroso earbamyglucos- amine. is an antibiotic and antitumor agent derived from Streptegyces achromoggnes (43,#4).. Rakietan and co- workers (as) first demonstrated that the drug could selec- tively destroy the pancreatic beta cell. with production of permanent diabetes. Increasing the dose of strepto- zotocin results in increased severity of the diabetes (#6). MATERIALS AND METHODS Animal Treatment. All animals were housed in an air- conditioned room at 23°C under controlled lighting (lights 6AM-6PM). Male Holtzman rats weighingIVZ50 grams were housed in groups of 4 in plastic cages containing wood chips. All groups were fed a commercial chow and H20, 2Q libitum. throughout the experiments. Diabetes was induced in rats by injection of streptozotocin (The Upjohn Co.) (65mg/ml/kg BW in 0.1 M citrate buffer, pH “.5) into the femoral vein within 10 minutes of solution preparation. Seven days after injection, blood was collected from the tail vein and analyzed for glucose levels. Only animals 80 with glucose levels of or above #00 mg% were used in the experiment. Eight days after streptozotocin injection. animals were injected with Regular Insulin i.p. (BU/100 grams BW) or Lente Insulin subcutaneously (lSU/lOO grams BW). Some groups received daily injections of Lente Insulin (l5U/100 grams BW) subcutaneously while the single injection group received Regular Insulin i.p. At time intervals after injection of insulin, rats were sacrificed by decapitation and trunk blood was collected in heparinized tubues. Livers were removed and free and polymerized tubulin were measured using a colchicine binding assay (see Chapter I for methods). Glucose Determination. Plasma glucose was determined by using the Computer-Directed 3500 Gilford Analyzer and the Gilford/Worthington reagent kit. Insulin Determination. An Insulin Radioimmunoassay kit (Amersham) was used to measure plasma insulin. Protein Determination. Liver tissue was homogenized in PBS and protein concentration was determined by the method of Lowry and co-workers (17) which was modified for auto- mated analysis as described by Mak and Wells (39). 235 Determination. DNA content was measured in liver homogenates (PBS) by the Ethidium Bromide method as des- cribed by Kurtz and Wells (18). Statistics. Statistical Analyses were performed using the two-tailed t-test (9.7). 81 RESULTS The protocol of the experiment is explained in Table I. To study the effects of diabetes on tubulin content and polymerizatin. rats were sacrificed 3. 8. and 14 days after streptozotocin injection at which time free and polymerized tubulin were measured. The eight day diabetic rats were given insulin injections. Therefore, the 14 day diabetic group would correlate with the 8 day diabetic group, 6 days after insulin injection. In order to verify the physiological state of the rat, plasma insulin and glucose levels were measured. Plasma glucose levels are elevated in the diabetic groups and decrease to approximately control levels after insulin injections (Table II). Twenty four hours after a single insulin injection plasma glucose levels are elevated again to those of diabetics. Repeated injections of insulin for 6 days results in abnormally low plasma glucose levels. Plasma insulin levels do not appear to be depressed in diabetic rats as compared to citrate injected rats (Table II). These results have been confirmed by other experi- ments. Streptozotocin injected rats which are injected with a single dose of insulin and allowed to become hyper- glycemic again have lower insulin levels than diabetic rats which have not been given insulin. The antibody used in the radioimmuncassay to quantitate plasma insulin may be cross-reacting with a plasma component which does not have insulin-like activity. Diabetics' (streptozotocin 82 TABLE I Protocol of Experiment and Body Weight of Rats Explanation of Treatment Code Weight of Rats Citrate injection C 281 i 33 Citrate injection, 14 hrs. 6 I (ip) C-I 290 i 8 3 days after streptozotocin 3D 255 i L? 8 days after streptozotocin SD _247 i 30 1“ days after streptozotocin lhD 285 i 22 8D, 1 hr. with Insulin (ip) lH-I 260 1 16 8D, 4 hrs. with Insulin (ip) #H-I 255 i 15 8D, 3 hrs. with Insulin (ip), QHZ-I 263 i 12 then another insulin injection (ip), 1 hr. later sacrificed 8D, 2# hrs. with Insulin (ip) 24-1 251 i 9 8D, 6 days with Insulin (ip) 6DI 275 i 9 8D, 6 days with Insulin (subcu) 6DR 313 1 3 given one insulin injection per day Male Holtzman rats were in ected with streptozotocin (controls were injected with citrate). Some rats were sacrificed at time intervals after streptozotocin injection. Eight days after stre tozotocin injection some rats were injected with insulin (I . At time intervals after insulin injections rats were sacrificed. A group of rats injected with citrate were)injected with insulin and 1# hours later sacrificed (3‘1 0 ip - interperitoneal subcu - subcutaneous 83 as.~ H Hm.sa ma. H aH.H owHA H.mH H «.00 «no mm.H H sm.om ea. H sm.H N.HH H m.mm m.nm H w.aam How mm. H me.o~ :0. H mm. m.o~ H m.ne s.os H H.mom Humsw as.m H m~.wH ea. H ma.H owHA s.o~ H m.~HH H-Nae n~.m H om.~m ms. H em. omas N.m H o.moa Hus: om.~ H oa.o~ mm. H 2H.H n.0H H o.om m.ms H m.smH H-:H mm. H :m.o~ as. H se.a e.mH H o.ms s.sn H ~.oos and mo. H Hm.mH NH. H 0:.H ~.om H o.so H.ms H H.mmm ow ms.H H ms.ma mm. H on.H m.oa H o.mm H.o~ H o.an am ma.s H oo.oa as. H om.H N.H H m.mm a.n~ H e.nma Huo sm.a H se.ma mm. H mm.a 2.0n H n.oe m.w H o.m~a o 00H x :HmHoam ms om>HA \cflasnse HE\:: R we macaw \cflmpoam Haves mo w: :HHSmsH omoosaw amazoswmeaxm HsmHCoo :Hepomm so uemmm :HHsDSB oo>Hq Hence was .pCmpcoo cHoHomm am>wq .mao>mq smasmcH can mwoosaw mammam HH mqmHq Hem caponsfla vooscsH afloopouopmoupm was s« sedvsuwaoshaom swasnsa mo cannon ess .H onswwm masoao HdHSosHaeaxm mac Haw 23m 783 . ES 75 9: am am To U _ _ fl _ _ _ _ _ _ _ _ (%) peztiamfitog uttnqnm JO iueoaeg sum 1 87 Figure II: Each value is the mean 1: standard deviation of 14» animals. ‘ *Significantly different from citrate in- jected rats (C) at a P<.05 by a two-tailed t'testo _ Asignifioantly different from 8 day diabetics (8D) at a P<.05 by a two-tailed t-test. 88 .vam,0HHonan voosusH sHocHouopaosHm on» Ga ao>HA some Mom :Hasnsa uosHuoszaom use seam mo vssos< one .HH mhswfim madame asvsoaHuoaxm m8 So 75% Hams: H43 75 9: am on Huo 0 _ _ l _ _ a _ _ _ omN_~_w<<>._O a». on 2: omH oom mextq J0 S/uttnqnm :0 Sn 89 Figure III: The Amount of Free and Polymerized Liver Tubulin per Mg DNA in the Streptozotocin Induced Diabetic Rat. Each value is the mean 1 standard deviation of 4 animals. 9O mam Haw Hux3N Himma Him: HImH masoac Hapsosanoaxm mad Ow l _ _ _ _ _ meN_~_m<<>._Om SE! ‘9 mm on mm OOH mma ma 3:0 Sm/unnqnj, 3:0 Bu 91 polymerization. Liver protein was measured in order to observe the effects of streptozotocin and insulin injections on this parameter, as well as being able to express tubulin content in terms of protein content, The amount of protein in the liver evidently does not decrease as much in diabetesg as do other tissue constituents (Table II). After insulin injections the amount of protein per mg tissue stays con- stant. The amount of total tubulin per mg protein does not change after streptozotocin injection. After insulin injection the pattern of tubulin amount per mg protein (Table II) resembles that of tubulin amount per mg DNA or per gram liver (Figures II & III). A decrease in the free form of tubulin per mg protein occurs 2b hours after insulin injection and then, a subsequent increase to dia- betic levels 5 days later. DISCUSSION As stated earlier microtubules have been implicated in VLDL and plasma protein secretion from the liver. The starved-refed rat system, because of its increased liver lipogenesis, VLDL synthesis, and VLDL secretion, seemed an ideal system in which to study microtubule regulation. From our starved-refed rat studies, an increase in tubulin polymerization appeared to correlate with the time at which an increase in VLDL secretion would occur. Studies with perfused liver or isolated hepatocytes 92 show that there is an impaired secretion of proteins in diabetic rats (24,30,31). This defect (impaired secretion of proteins) may be related to the marked disruption of the rough endoplasmic reticulum (RER), which has been seen in livers of streptozotocin injected rats (export proteins are synthesized almost exclusively on the RER) (23,32). Investigators have observed not only the extensive dis- ruption of BBB, but also appearance of large lysosomes. With chronic insulin treatment the ultrastructure of the cell is restored (23). The rate of albumin synthesis and secretion has been reported to be markedly reduced in dia- betes (2h.33). Treatment of diabetic rats with insulin restores rates of synthesis and secretion of albumin. Insulin has been shown to stimulate hepatic lipogenesis (8-14) and may increase triglyceride secretion from the liver (14-16). In view of the link between hepatic albu- min and triglyceride secretion and the diabetic rat, we thought this would also be an ideal system to study micro- tubule regulation. In the diabetic rat, an insulin injection produced an increase in the degree of tubulin polymerization. This increase in the degree of tubulin polymerization, at a time when an increase in hepatic VLDL and plasma protein may occur, would suggest that microtubules may be involved in secretion in the diabetic, insulin treated rat. The problem was the increase in the degree of tubulin 93 polymerization was due to an decrease in the free form rather than an increase in the polymerized form. For this reason we are not able to discuss whether micro- tubules are involved in the secretion process in the dia- betic rat system._ Tubulin content and polymerization can be independently modulated by physiological factors in the diabetic rat, but further work must be done to eluci- date these factors as well as to explain the role of microtubules in this system. We did not see a correlation between insulin or glucose levels and tubulin content and polymerization in the starved-refed rat. In view of the extreme changes in glucose and insulin levels in the diabetic rat, a cor- relation may be able to be detected in this system. We failed to detect any correlation between insulin or glucose levels and tubulin content and polymerization. 9. 10. 11. 12. l3. 14. 15. BIBLIOGRAPHY Pipeleers, D. G.. Pipeleers-Marichal, M. A.. Sherline. Pa, and Kipnis, D. M. (1977), g; Cell Biol. 24. 341. Wagle, S. R.. Ingebretsen, J. R.. and Sampson, L. (1975), Diabetologia 1;, 411. Ichihara, K. 9and Murad, F. (1979), Arch. Biochem. Bio- phys.124, 2. Reaven, E. P. and Reaven, G. M. (1974),_Clin Invest. , e Soman. V. and Felig, P. (1978), g; Clin. Invest. 61. 552. Bhathena, S. J.. Voyles. N. R.. Smith, S., and Recant, L. (1978), J; Clin. Invest. 61. 1488. Seitz. H. J.. Muller, M. J.. Krone. W.. and Tarnowski. W. (1977), Diabetes 26. 1159. Altman, K.. Miller. L. L.. and Bly, C. G. (1951). Arch. Biochem. Biophys: 31, 329. Bloch, K. and Kramer. W. (1948), J; Biol. Chem. 123, 81 Egady, R. O. and Gurin, S. (1950), g; Biol. Chem. 186, 1 Brady, R. 0.. Lukens. F. D. W.. and Gurin, S. (1951), Science 113. 413. Haft, D. E. (1967), Amer. 1. Phys. g}. 219. Haft. D. E. and Miller. L. L. (1958), Amer. g; Phys. 122. 33. Topping, D. L. and Mayes, P. A. (1972), Biochem. g; 126, 295. Reaven. G. M.. Lerner, R. L.. Stern, M. P.. and Farquhar, J. W. (1967), J. Clin. Invest. 11, 1756. 94 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30- 31. 32. 95 Farquhar, J.W ., Fra nk, A.. Gross, R. C., and Reaven, G. M. (1966), J. Clin. Invest. _5,11648 8. Lowry. O. H.. Rosebrough, N. J.. Farr, A. L.. and Randall, R. .(1951), J. Biol. Chem. 123, 265. Kurtz, J. W. and Wells, W. W. (1979), Anal. Biochem. 24, 166. Bar-0n, He. ROheim. P. So. and Eder. He A0 (1976), Diabetes 25, 509. Schein. P. S.. Alberti. K. G. M. M.. and Williamson, D. H. (1971). Endocrinology _2. 827 7. Schnatz, J. D.. Formaniak, J. M.. and Chlouverakis. C. (1972), Diabetologia 8. 125. Pain, V. M. and Garlick, P. J. (1974), g; Biol, Chem. a2, 4510. Pain. V. M.. Lanoix. J.. Bergerson, J. J. M.. and Clemens, M. J. (1974), Biochim. Biophys. Acta 353, 487. Peavy, D. E.. Taylor, J. M.. Jefferson, L. S. (1978), Proc. Natl. Acad. Sci. USA 25, 5879. Mortimore, G. 7E. and Mondon. C. E. (1970), g; Biol. Chem. M5. 5. Jefferson, L. S.. Li, J. B.. and Rannels. S. R. (1977). L Biol. Chem, 22. 1476. Morgan. H. E.. Jefferson, L. S.. Wolpert, E. B.. and Rannels. D. E. (1971), J. Biol, Chem. 246, 2163. ‘ Goldberg, A. L. and St. John, A. (1976). Annual Review of Biochemistry _j. 747. ‘ Dice, F. J.. Walker, C. D.. Byrne, B.. and Cardiel, A. (1978), Proc: Natl. Acad. Sci. USA 21. 2093. Green, M. and Miller, L. L. (1960), Amer. J; Phys: 235, 3202. Ingebretsen, W. R.. Moxley, M. A.. Allen. D. 0.. and fiaglg, S. R. (1972), Biochem. Biophyg. Res. Commun. _2, 01. Reaven, E. P.. Peterson, D. T.. and Reaven. G. M. (1973), g; Clin. Invest. fig. 248. 33- 35. 36. 37. 38- 39. 40. 1+1. 42. 43. 45. 46. 47. 96 Dich, J. (1973) 9th Int. Cong. Biochem. Stokholm, Abstr. 149, Aktiebologet Eggellska, Boktryckeriet, Stockholm Le Marchand, Y., Singh. A., Assimacopoulos-Jeannet, F.. Orci. L.. Rouiller, C., and Jeanrenaud. B. (1973), g; Biol. Chem. 248. 6862. Stein.“ 0. and Stein, Y. (1973), Biochim. BiophxsI Acta 1%:12- Orci. L.. Le Marchend, Y.. Singh. A.. Assimacopoulos- Jeannet, F.. Rouiller, C., and Jeanrenaud. B. (1973), Nature 244, 30. Stein. 0., Sanger. L.. and Stein. Y. (1974), L. Cell Biol 62, 90. Sin h, A., Le Marchand, Y., Orci. L.. and Jeanrenaud. %l975), Eurl g; Clin: Invest, 5. 95. . T. and 3Wells, W. W. (1977). Arch. Biochem. Biophys.l 83,3 8. Redman, C. M.. Banerjee. D.. Howell, K., and Palade, G. E. (1975). g. Cell Biol. 66, 42 Redman. C. M.. Banerjee. D.. Manning, C., Huang. C. Y., Green. K. (1978), g; Cell Biol. 21, 400. Le Marchand, Y., Patzelt, C., Assimacopoulos-Jeannet, F.. Rouiller, C., and Jeanrenaud. B. (1974), g. Clin. Invest. 52, 1512. Herr, R. 2.5 Eble T. E.. Bergy, M. E.. and Jahnke, H. K. 19 0 Antibiot. Ann,1952-m9 New York Medical Encyélo pedia,I Inc.. New York, p. 236 . Herr. R. R.. Jahnke, H. K., and Argoudelio. A. D. (1967), L. Amer. Chem. Soc. _2. 18 . Rakieten, N., Rakieten, M. RL., and Nadkarni. M. V. (1963), Cancer Chemother. Rep. _2. 91. Junod, A., Lambert, A. E.. Stauffacher. W.. and Renold, A. E. (1969), g; Clin. Invest, 48, 2129. Steele, R. G. P. and Torrie J. H. (1960). Principles and Procedures 9; Statistics. McGraw-Hill Co.. Inc.. New York. B ‘ mfi'm'fitfigfixMIMIflfiflflffliflfifijflflfllflflfilflES h‘wflgfim‘*;{wzfirquuu ‘ _ ‘ . .. . .